Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Circ Cardiovasc Genet. 2016 Oct 26;9(6):495–503. doi: 10.1161/CIRCGENETICS.116.001457

Table 1.

Unweighted and weighted genetic risk scores - trait associations at baseline (Nmax=2,585)

Trait (units) GRS N β SE P 95%
CI LL
95%
CI UL
PwGRS β inv SEinv Pinv PwGRSinv
ApoB (g/l) ApoB GRS 2,567 0.014 0.002 1.9E-10 0.01 0.018 2.2E-25 0.058 0.009 8.0E-11 4.3E-26
ApoB (g/l) LDL-C GRS 2,567 0.007 0.001 2.8E-11 0.005 0.009 1.4E-14 0.03 0.004 1.9E-11 4.0E-15
ApoB (g/l) TC GRS 2,567 0.006 0.001 4.2E-12 0.005 0.008 1.6E-18 0.027 0.004 2.1E-12 6.5E-19
HDL size
(nm)
HDL size
GRS
1,714 −0.018 0.004 1.3E-05 −0.026 −0.01 5.7E-08 −0.04 0.01 8.6E-05 6.4E-07
HDL-C
(mmol/l)
HDL-C GRS 2,584 −0.007 0.001 1.9E-12 −0.01 −0.005 4.2E-31 −0.027 0.003 1.6E-14 1.8E-36
IDL-C
(nmol/l)
IDL-C GRS 1,710 −1.568 1.409 2.7E-01 −4.332 1.197 4.6E-01 −0.011 0.013 4.1E-01 4.4E-01
large HDL
(μmol/l)
HDL-C GRS 1,712 −0.052 0.01 5.6E-07 −0.073 −0.032 6.6E-15 −0.023 0.004 4.8E-08 4.4E-16
large HDL
(μmol/l)
large HDL
GRS
1,712 −0.151 0.026 5.7E-09 −0.202 −0.1 4.9E-13 −0.06 0.01 6.2E-09 1.2E-12
large LDL
(nmol/l)
HDL-C GRS 1,632 −4.903 1.152 2.2E-05 −7.162 −2.644 4.2E-12 −0.021 0.005 7.2E-06 4.4E-13
large LDL
(nmol/l)
large LDL
GRS
1,632 13.644 2.257 1.8E-09 9.217 18.072 8.8E-12 0.053 0.009 4.4E-09 6.0E-11
large VLDL
(nmol/l)
large VLDL
GRS
1,714 0.353 0.088 6.9E-05 0.179 0.526 1.5E-04 0.049 0.012 2.4E-05 1.7E-05
large VLDL
(nmol/l)
TG GRS 1,714 0.261 0.045 9.3E-09 0.172 0.349 2.0E-17 0.035 0.006 3.5E-09 2.4E-18
LDL size
(nm)
HDL-C GRS 2,585 −0.073 0.011 1.7E-11 −0.094 −0.052 1.7E-16 −0.023 0.004 1.1E-10 9.6E-16
LDL size
(nm)
LDL size
GRS
2,585 0.172 0.023 5.2E-14 0.127 0.216 2.8E-12 0.055 0.008 6.8E-13 1.2E-11
LDL size
(nm)
TG GRS 2,585 −0.119 0.015 2.8E-15 −0.149 −0.09 5.3E-18 −0.039 0.005 5.8E-15 7.1E-18
LDL-C
(mmol/l)
LDL-C GRS 2,584 0.027 0.004 1.4E-12 0.02 0.034 4.2E-18 0.032 0.004 7.7E-13 2.6E-18
medium HDL
(μmol/l)
medium HDL
GRS
1,714 −0.045 0.077 5.6E-01 −0.196 0.105 4.0E-01 −0.009 0.014 5.4E-01 4.0E-01
medium VLDL
(nmol/l)
medium
VLDL GRS
1,707 1.113 0.236 2.5E-06 0.651 1.575 6.5E-03 0.056 0.012 1.3E-06 7.3E-03
medium VLDL
(nmol/l)
TG GRS 1,707 0.483 0.123 9.1E-05 0.241 0.725 1.1E-11 0.024 0.006 5.6E-05 5.0E-12
small HDL
(μmol/l)
small HDL
GRS
1,713 −0.366 0.056 6.2E-11 −0.475 −0.257 6.8E-19 −0.076 0.012 7.9E-11 9.6E-19
small LDL
(nmol/l)
HDL-C GRS 1,714 8.772 1.793 1.1E-06 5.256 12.289 1.2E-11 0.022 0.004 6.3E-07 6.4E-12
small LDL
(nmol/l)
small LDL
GRS
1,714 26.807 4.017 3.4E-11 18.929 34.685 1.2E-09 0.067 0.01 3.2E-11 1.3E-09
small VLDL
(nmol/l)
small VLDL
GRS
1,708 0.83 0.182 5.6E-06 0.473 1.187 6.3E-08 0.045 0.01 1.6E-05 2.0E-07
TC
(mmol/l)
TC GRS 2,584 0.029 0.004 2.4E-16 0.022 0.036 2.2E-24 0.031 0.004 2.1E-16 2.2E-24
TG
(mmol/l)
TG GRS 2,584 0.043 0.005 2.5E-15 0.033 0.054 6.0E-24 0.041 0.005 1.1E-16 1.7E-26
total HDL
(μmol/l)
HDL-C GRS 1,711 −0.051 0.027 5.7E-02 −0.103 0.002 1.2E-04 −0.01 0.004 2.8E-02 4.4E-05
total HDL
(μmol/l)
total HDL
GRS
1,711 −0.517 0.094 4.7E-08 −0.702 −0.332 1.6E-10 −0.087 0.015 1.9E-08 7.0E-11
total LDL
(nmol/l)
LDL-C GRS 1,714 9.782 2.064 2.3E-06 5.734 13.829 5.0E-08 0.027 0.005 9.9E-07 3.0E-08
total LDL
(nmol/l)
TC GRS 1,714 8.442 1.786 2.5E-06 4.94 11.945 3.9E-09 0.023 0.005 1.1E-06 1.7E-09
total LDL
(nmol/l)
total LDL
GRS
1,714 14.083 3.67 1.3E-04 6.884 21.281 3.1E-08 0.037 0.01 1.1E-04 2.9E-08
total VLDL
(nmol/l)
TG GRS 1,714 0.885 0.205 1.6E-05 0.483 1.286 3.8E-11 0.026 0.006 1.7E-05 5.4E-11
total VLDL
(nmol/l)
total VLDL
GRS
1,714 2.467 0.362 1.3E-11 1.757 3.177 1.2E-08 0.072 0.011 1.1E-11 1.5E-08
VLDL size
(nm)
TG GRS 1,648 0.255 0.054 2.4E-06 0.149 0.361 1.4E-11 0.029 0.006 8.0E-06 5.8E-11
VLDL size
(nm)
VLDL size
GRS
1,648 0.579 0.131 1.0E-05 0.323 0.835 9.5E-08 0.066 0.015 1.9E-05 1.6E-07

95% CI LL - 95% confidence interval lower limit; 95% CI UL - 95% confidence interval upper limit; ApoB - apolipoprotein B; β - beta effect estimate; βinv – beta effect estimate for inverse normalized traits; DPP - Diabetes Prevention Program; GRS - genetic risk score per GRS risk allele; HDL - high density lipoprotein; IDL - intermediate density lipoprotein; inv – inverse normalized traits; LDL - low density lipoprotein; N - sample size; PinvP value for inverse normalized traits; PwGRSP value for weighted genetic risk score associations; PwGRSinvP value for weighted genetic risk score associations undertaken with the inverse normalized traits; SE - standard error; SEinv – standard error for inverse normalized traits; TC - total cholesterol; TG - triglyceride; VLDL - very low density lipoprotein; wGRS - weighted genetic risk score.

P values are based on linear regression models. SNP associations were tested by fitting the genetic risk scores as the independent variables with the different lipoprotein subfractions at baseline as dependent variables. β coefficients reflect the association of one genetic risk score unit (effect allele) with the trait (expressed in native units and inverse normalized units).

Age, age2, sex and genomic principal components were used as covariates in all models.